Tumor Ablation Market Overview

The report is titled as ‘Tumor Ablation Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the tumor ablation market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Tumor ablation market is expected to grow with significant rate in the near future.

The global tumor ablation market in 2020 is estimated for more than US$ 1.3 Bn and expected to reach a value of US$ 3.0 Bn by 2028 with a significant CAGR of 11.1%

MMC Overview

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Tumor Ablation market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Tumor Ablation Market Key Players

Some of the key participating players in global tumor ablation market are

Medtronic plc

Angiodynamics, Inc.

Boston Scientific Corporation

Galil Medical, Inc.

EDAP TMS S.A.

Healthtronics, Inc.

Mermaid Medical, Inc.

Mesonix, Inc.

Neuwave Medical, Inc.

Sonacare Medical, LLC

Tumor Ablation Market Segmentation

The global tumor ablation market is segmented on the basis of technology, mode of treatment, application, and region.

On Basis of Technology

Radiofrequency (RF) Ablation

Microwave Ablation

Cryoablation

Other Technologies

On Basis of Mode of Treatment

Surgical Ablation

Laparoscopic Ablation

Percutaneous Ablation

On Basis of Application

Liver Cancer

Lung Cancer

Kidney Cancer

Bone Metastasis

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

1.    Global Tumor Ablation Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Tumor Ablation Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Tumor Ablation Market Snapshot

2.4.    Global Tumor Ablation Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Tumor Ablation Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Tumor Ablation Market, By Technology

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Technology

3.1.2.    BPS Analysis, By Technology

3.2.    Market Revenue (US$Mn) Forecast, By Technology

3.2.1.    Radiofrequency (RF) Ablation 

3.2.2.    Microwave Ablation

3.2.3.    Cryoablation 

3.2.4.    Other Technologies

3.3.    Global Tumor Ablation Market Attractiveness Index, By Technology

4.    Global Tumor Ablation Market, By Mode of Treatment

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Mode of Treatment

4.1.2.    BPS Analysis, By Mode of Treatment

4.2.    Market Revenue (US$Mn) Forecast, By Mode of Treatment

4.2.1.    Surgical Ablation

4.2.2.    Laparoscopic Ablation 

4.2.3.    Percutaneous Ablation

4.3.    Global Tumor Ablation Market Attractiveness Index, By Mode of Treatment

5.    Global Tumor Ablation Market, By Application

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Application

5.1.2.    BPS Analysis, By Application

5.2.    Market Revenue (US$Mn) Forecast, By Application

5.2.1.    Liver Cancer

5.2.2.    Lung Cancer

5.2.3.    Kidney Cancer

5.2.4.    Bone Metastasis

5.2.5.    Others

5.3.    Global Tumor Ablation Market Attractiveness Index, By Application

6.    Global Tumor Ablation Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Tumor Ablation Market Attractiveness Index, By Region

7.    North America Tumor Ablation Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Tumor Ablation Market

7.2.2.    Canada Tumor Ablation Market

7.3.    North America Tumor Ablation Market, By Technology

7.3.1.    Radiofrequency (RF) Ablation 

7.3.2.    Microwave Ablation

7.3.3.    Cryoablation 

7.3.4.    Other Technologies

7.4.    North America Tumor Ablation Market, By Mode of Treatment

7.4.1.    Surgical Ablation

7.4.2.    Laparoscopic Ablation 

7.4.3.    Percutaneous Ablation

7.5.    North America Tumor Ablation Market, By Application

7.5.1.    Liver Cancer

7.5.2.    Lung Cancer

7.5.3.    Kidney Cancer

7.5.4.    Bone Metastasis

7.5.5.    Others

7.6.    North America Tumor Ablation Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Technology

7.6.3.    By Mode of Treatment

7.6.4.    By Application

8.    Latin America Tumor Ablation Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Tumor Ablation Market

8.2.2.    Mexico Tumor Ablation Market

8.2.3.    Argentina Tumor Ablation Market

8.2.4.    Rest of Latin America Tumor Ablation Market

8.3.    Latin America Tumor Ablation Market, By Technology

8.3.1.    Radiofrequency (RF) Ablation 

8.3.2.    Microwave Ablation

8.3.3.    Cryoablation 

8.3.4.    Other Technologies

8.4.    Latin America Tumor Ablation Market, By Mode of Treatment

8.4.1.    Surgical Ablation

8.4.2.    Laparoscopic Ablation 

8.4.3.    Percutaneous Ablation

8.5.    Latin America Tumor Ablation Market, By Application

8.5.1.    Liver Cancer

8.5.2.    Lung Cancer

8.5.3.    Kidney Cancer

8.5.4.    Bone Metastasis

8.5.5.    Others

8.6.    Latin America Tumor Ablation Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Technology

8.6.3.    By Mode of Treatment

8.6.4.    By Application

9.    Europe Tumor Ablation Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Tumor Ablation Market

9.2.2.    Germany Tumor Ablation Market

9.2.3.    Italy Tumor Ablation Market

9.2.4.    France Tumor Ablation Market

9.2.5.    Spain Tumor Ablation Market

9.2.6.    Russia Tumor Ablation Market

9.2.7.    Poland Tumor Ablation Market

9.2.8.    BENELUX Tumor Ablation Market

9.2.9.    NORDIC Tumor Ablation Market

9.2.10.    Rest of Europe Tumor Ablation Market

9.3.    Europe Tumor Ablation Market, By Technology

9.3.1.    Radiofrequency (RF) Ablation 

9.3.2.    Microwave Ablation

9.3.3.    Cryoablation 

9.3.4.    Other Technologies

9.4.    Europe Tumor Ablation Market, By Mode of Treatment

9.4.1.    Surgical Ablation

9.4.2.    Laparoscopic Ablation 

9.4.3.    Percutaneous Ablation

9.5.    Europe Tumor Ablation Market, By Application

9.5.1.    Liver Cancer

9.5.2.    Lung Cancer

9.5.3.    Kidney Cancer

9.5.4.    Bone Metastasis

9.5.5.    Others

9.6.    Europe Tumor Ablation Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Technology

9.6.3.    By Mode of Treatment

9.6.4.    By Application

10.    Asia Pacific Tumor Ablation Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Tumor Ablation Market

10.2.2.    India Tumor Ablation Market

10.2.3.    Japan Tumor Ablation Market

10.2.4.    Australia and New Zealand Tumor Ablation Market

10.2.5.    South Korea Tumor Ablation Market

10.2.6.    ASEAN Tumor Ablation Market

10.2.7.    Rest of Asia Pacific Tumor Ablation Market

10.3.    Asia Pacific Tumor Ablation Market, By Technology

10.3.1.    Radiofrequency (RF) Ablation 

10.3.2.    Microwave Ablation

10.3.3.    Cryoablation 

10.3.4.    Other Technologies

10.4.    Asia Pacific Tumor Ablation Market, By Mode of Treatment

10.4.1.    Surgical Ablation

10.4.2.    Laparoscopic Ablation 

10.4.3.    Percutaneous Ablation

10.5.    Asia Pacific Tumor Ablation Market, By Application

10.5.1.    Liver Cancer

10.5.2.    Lung Cancer

10.5.3.    Kidney Cancer

10.5.4.    Bone Metastasis

10.5.5.    Others

10.6.    Asia Pacific Tumor Ablation Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Technology

10.6.3.    By Mode of Treatment

10.6.4.    By Application

11.    Middle East Tumor Ablation Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Tumor Ablation Market

11.2.2.    Israel Tumor Ablation Market

11.2.3.    Oman Tumor Ablation Market

11.2.4.    Rest of Middle East Tumor Ablation Market

11.3.    Middle East Tumor Ablation Market, By Technology

11.3.1.    Radiofrequency (RF) Ablation 

11.3.2.    Microwave Ablation

11.3.3.    Cryoablation 

11.3.4.    Other Technologies

11.4.    Middle East Tumor Ablation Market, By Mode of Treatment

11.4.1.    Surgical Ablation

11.4.2.    Laparoscopic Ablation 

11.4.3.    Percutaneous Ablation

11.5.    Middle East Tumor Ablation Market, By Application

11.5.1.    Liver Cancer

11.5.2.    Lung Cancer

11.5.3.    Kidney Cancer

11.5.4.    Bone Metastasis

11.5.5.    Others

11.6.    Middle East Tumor Ablation Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Technology

11.6.3.    By Mode of Treatment

11.6.4.    By Application

12.    Africa Tumor Ablation Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Tumor Ablation Market

12.2.2.    Egypt Tumor Ablation Market

12.2.3.    North Africa Tumor Ablation Market

12.2.4.    Rest of Africa Tumor Ablation Market

12.3.    Africa Tumor Ablation Market, By Technology

12.3.1.    Radiofrequency (RF) Ablation 

12.3.2.    Microwave Ablation

12.3.3.    Cryoablation 

12.3.4.    Other Technologies

12.4.    Africa Tumor Ablation Market, By Mode of Treatment

12.4.1.    Surgical Ablation

12.4.2.    Laparoscopic Ablation 

12.4.3.    Percutaneous Ablation

12.5.    Africa Tumor Ablation Market, By Application

12.5.1.    Liver Cancer

12.5.2.    Lung Cancer

12.5.3.    Kidney Cancer

12.5.4.    Bone Metastasis

12.5.5.    Others

12.6.    Africa Tumor Ablation Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Technology

12.6.3.    By Mode of Treatment

12.6.4.    By Application

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Medtronic plc

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Technology Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Angiodynamics, Inc.

14.3.3.    Boston Scientific Corporation

14.3.4.    Galil Medical, Inc.

14.3.5.    EDAP TMS S.A.

14.3.6.    Healthtronics, Inc.

14.3.7.    Mermaid Medical, Inc.

14.3.8.    Mesonix, Inc.

14.3.9.    Neuwave Medical, Inc.

14.3.10.    Sonacare Medical, LLC

15.    Acronyms